Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
about
Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trialNeurodegeneration in multiple sclerosis: novel treatment strategiesStatins for the primary prevention of cardiovascular diseaseStatins for multiple sclerosisClinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizonsCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewStatin treatment in multiple sclerosis: a systematic review and meta-analysis.Effect of oral genistein administration in early and late phases of allergic encephalomyelitis.Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.Statin therapy and multiple sclerosis disability in a population-based cohort.Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS studyA randomized trial of stress management for the prevention of new brain lesions in MSAtorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trialHyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.Dietary pattern and risk of multiple sclerosis.Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins.Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.Lipid Control and Beyond: Current and Future Indications for Statin Therapy in Stroke.Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.Combining statins with interferon β in multiple sclerosis: think twice, it might not be all rightSimvastatin: Multiple Sclerosis.Statins amplify TLR-induced responses in microglia via inhibition of cholesterol biosynthesis.Simvastatin improves final visual outcome in acute optic neuritis: a randomized study.Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
P2860
Q21559486-B3346D48-1291-445F-A0C7-9FA8159672C9Q22241472-66624FBB-D6EA-428A-8323-712D1CD3B1C7Q24201513-10D0B445-901A-416D-A314-E7D25BDF33D6Q24234119-4998893D-8F8A-412D-94D0-84FBFCE7904AQ26752168-0CE96B7C-21D7-461F-928D-C8428F994FD5Q28076346-BA9E66C8-63A8-4DBE-B325-D93197C62148Q30913423-A1823AE1-86F7-4C0A-8624-6E5BEC9CEFC8Q34567115-AA3CA5DD-4062-4BD1-912A-87DB95449940Q35205220-9CA2D003-4422-41B6-A932-0B132AAA1270Q35612796-42E22538-8131-4252-BF57-B057CBD1B598Q35838945-C0BD383D-BA89-473F-A643-C442311585A0Q35872344-C9DACB56-0FF4-47CC-9C3E-8A464B574701Q36117334-C451316D-A81B-4225-91A2-83AF07CF589CQ36357176-77706F9D-11EC-499F-AF0A-D91C2196EF6FQ37247613-22CB264F-0130-4325-A7F5-16CF4EB8580FQ37311623-0971F779-0523-4FC8-AC85-3EE7A18C4493Q37543452-E4F425D9-2721-406D-B790-84DA43F0BC5FQ37580266-BA60C365-CEC8-4853-9AA6-1BB41D5355B7Q38020536-F6919BEA-98C5-4E1C-8A2B-866A8B1D7187Q38751939-DC23221D-2ACB-4645-A8CE-E99E23C25852Q40101603-193BD3D8-EA30-4E91-AD3F-8A8052F31A1AQ41841667-C9DD283F-0152-437C-8889-6004537BBE8CQ43225143-86D4FE64-ED10-4719-A994-DDD5129718B4Q48867291-AAB1E97E-F9E5-46A9-87FD-3C4AF69A9821Q48896378-038EC02C-09D7-466A-845C-F07789E0420DQ49139039-F132F870-2983-4E86-B5A1-41A18B62EE54Q52147931-5D03194A-3AF8-4F75-8864-82384326E748
P2860
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Simvastatin treatment in patie ...... d randomized controlled trial.
@en
Simvastatin treatment in patie ...... d randomized controlled trial.
@nl
type
label
Simvastatin treatment in patie ...... d randomized controlled trial.
@en
Simvastatin treatment in patie ...... d randomized controlled trial.
@nl
prefLabel
Simvastatin treatment in patie ...... d randomized controlled trial.
@en
Simvastatin treatment in patie ...... d randomized controlled trial.
@nl
P2093
P2860
P50
P356
P1476
Simvastatin treatment in patie ...... d randomized controlled trial.
@en
P2093
Alireza Nourian
Anahita Enzevaei
Hossein Ghanaati
Kavous Firouznia
Majid Shekiba
Mansoureh Togha
Masoud Nabavi
Mohammad Hossein Harirchian
Sanaz Ahmadi Karvigh
P2860
P304
P356
10.1177/1352458510369147
P577
2010-05-20T00:00:00Z